TAS-102 is an orally administered combination of a thymidine-based nucleic acid analogue, trifluridine, and a thymidine phosphorylase inhibitor, tipiracil hydrochloride.
TrustPilot
Ayesha M.
5天前
阿里·H.
1天前
阿卜杜拉·B.
3 周前
伊姆兰 F.
2 周前